Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Protective effects of statins on COVID-19 risk, severity and fatal outcome: a nationwide Swedish cohort study
Ailiana Santosa, Stefan Franzén, Jonatan Nåtman, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Anti-Inflammatory Effects of Lipid-Lowering Drugs and Supplements—A Narrative Review
Stefan Zivkovic, Gorica Marić, Nataša Cvetinovic, et al.
Nutrients (2023) Vol. 15, Iss. 6, pp. 1517-1517
Open Access | Times Cited: 25
Preparing for the next viral threat with broad-spectrum antivirals
Marwah Karim, Chieh‐Wen Lo, Shirit Einav
Journal of Clinical Investigation (2023) Vol. 133, Iss. 11
Open Access | Times Cited: 24
Effectiveness of Drug Repurposing and Natural Products Against SARS-CoV-2: A Comprehensive Review
Paula Andrea Cuartas Velásquez, Juan C. Hernández, Elkin Galeano, et al.
Clinical Pharmacology Advances and Applications (2024) Vol. Volume 16, pp. 1-25
Open Access | Times Cited: 10
Metabolic regulation of type I interferon production
Shane M. O’Carroll, Fiona Henkel, Luke O'neill
Immunological Reviews (2024) Vol. 323, Iss. 1, pp. 276-287
Open Access | Times Cited: 10
Lipid-targeting antiviral strategies: current state and future perspectives
Ana-Belén Blázquez, Patricia Mingo‐Casas, Ernesto Quesada, et al.
Antiviral Research (2025), pp. 106103-106103
Closed Access
Atherosclerosis, Cardiovascular Disease, and COVID-19: A Narrative Review
Carles Vilaplana-Carnerero, Maria Giner‐Soriano, Ángela Domı́nguez, et al.
Biomedicines (2023) Vol. 11, Iss. 4, pp. 1206-1206
Open Access | Times Cited: 14
Role of PCSK9 inhibition during the inflammatory stage of SARS-COV-2: an updated review
Hina Arsh, FNU Manoj Kumar, FNU Simran, et al.
Annals of Medicine and Surgery (2024) Vol. 86, Iss. 2, pp. 899-908
Open Access | Times Cited: 4
Systematic Review and Meta-Analysis of Statin Use and Mortality, Intensive Care Unit Admission and Requirement for Mechanical Ventilation in COVID-19 Patients
Ut-Sam Lao, Chak-Fun Law, Daniel T. Baptista‐Hon, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 18, pp. 5454-5454
Open Access | Times Cited: 19
Lipid rafts disruption by statins negatively impacts the interaction between SARS-CoV-2 S1 subunit and ACE2 in intestinal epithelial cells
Marianne El Khoury, Hassan Y. Naim
Frontiers in Microbiology (2024) Vol. 14
Open Access | Times Cited: 3
Relationship between 2nd-generation angiotensin receptor blockers and the risk of hypotension in COVID-19 patients admitted to hospital
Fumiki Yoshihara, Yasushi Matsuzawa, Kiyomasa Nakatsuka, et al.
Hypertension Research (2024) Vol. 47, Iss. 7, pp. 1943-1951
Closed Access | Times Cited: 3
The impact of statin therapy on in‐hospital prognosis and endothelial function of patients at high‐to‐very high cardiovascular risk admitted for COVID‐19
Vanessa Bianconi, Massimo R. Mannarino, Elena Cosentini, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 3
Closed Access | Times Cited: 7
Familial hypercholesterolemia: The nexus of endothelial dysfunction and lipoprotein metabolism in COVID-19
Alpo Vuorio, Frederick J. Raal, Petri T. Kovanen
Current Opinion in Lipidology (2023) Vol. 34, Iss. 3, pp. 119-125
Closed Access | Times Cited: 5
Coronary microcirculatory dysfunction in hypercholesterolemic patients with COVID-19: potential benefit from cholesterol-lowering treatment
Alpo Vuorio, Petri T. Kovanen, Frederick J. Raal
Annals of Medicine (2023) Vol. 55, Iss. 1
Open Access | Times Cited: 5
SARS-CoV-2 reinfection: Adding insult to dysfunctional endothelium in patients with atherosclerotic cardiovascular disease
Petri T. Kovanen, Alpo Vuorio
Atherosclerosis Plus (2023) Vol. 53, pp. 1-5
Open Access | Times Cited: 5
Direct pharmacological AMPK activation inhibits mucosal SARS-CoV-2 infection by reducing lipid metabolism, restoring autophagy flux and the type I IFN response
Andréa Cottignies-Calamarte, Flora Marteau, Feifan He, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Correlations between preoperative statin treatment with short- and long-term survival following colorectal cancer surgery: a propensity score-matched national cohort study
Lea Löffler, Ismail Gögenür, Mikail Gögenur
International Journal of Colorectal Disease (2024) Vol. 39, Iss. 1
Open Access | Times Cited: 1
Effects of Pitavastatin on COVID-19 Incidence and Seriousness among a Global Cohort of People with HIV
Markella V. Zanni, Triin Umbleja, Carl J. Fichtenbaum, et al.
Open Forum Infectious Diseases (2024) Vol. 11, Iss. 10
Open Access | Times Cited: 1
Association of Cardiovascular Medications With Adverse Outcomes in a Matched Analysis of a National Cohort of Patients With COVID-19
Leonard Kuan‐Pei Wang, Yong‐Fang Kuo, Jordan Westra, et al.
American Journal of Medicine Open (2023) Vol. 9, pp. 100040-100040
Open Access | Times Cited: 4
Impact of in-hospital statin use on mortality in COVID-19 patients from a majority African American population
Nitish Sood, Dhairya Shukla, Pranjal Mishra, et al.
Heart & Lung (2023) Vol. 64, pp. 137-141
Open Access | Times Cited: 3
Barriers and shortcomings in access to cardiovascular management and prevention for familial hypercholesterolemia during the COVID‐19 pandemic
Helen Huang, Keith Sai Kit Leung, Tulika Garg, et al.
Clinical Cardiology (2023) Vol. 46, Iss. 8, pp. 831-844
Open Access | Times Cited: 3
Hypercapnia increases ACE2 expression and pseudo-SARS-CoV-2 entry in bronchial epithelial cells by augmenting cellular cholesterol
Fei Chen, Aiko Matsuda, G. R. Scott Budinger, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
Association of antecedent statin use on 30-day, 60-day and 90-day mortality among Mississippi Medicaid beneficiaries diagnosed with COVID-19
Yiran Rong, Swarnali Goswami, O Eriakha, et al.
BMJ Open (2023) Vol. 13, Iss. 11, pp. e076195-e076195
Open Access | Times Cited: 3
Statin and aspirin use in parasitic infections as a potential therapeutic strategy: A narrative review
Valentina Burgess, Juan Diego Maya
Revista Argentina de Microbiología (2023) Vol. 55, Iss. 3, pp. 278-288
Open Access | Times Cited: 2
Mass spectrometric approaches in discovering lipid biomarkers for COVID‐19 by lipidomics: Future challenges and perspectives
Siddabasave Gowda B. Gowda, Chandra Shekhar, Divyavani Gowda, et al.
Mass Spectrometry Reviews (2023) Vol. 43, Iss. 5, pp. 1041-1065
Closed Access | Times Cited: 2
Correlations between pre-operative statin-treatment with short- and long-term survival following colorectal cancer surgery: A propensity score-matched national cohort study
Lea Löffler, Ismail Gögenür, Mikail Gögenur
Research Square (Research Square) (2024)
Open Access
Page 1 - Next Page

Scroll to top